INB03

· Inmune Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INB03, covering 2022-03-18 to 2022-03-18. Get the full timeline:

Most recent: Clinical Trial Update: INB03 for the Treatment of Pulmonary Complications From COVID-19 [Phase 2, Phase 3]